The current and future state of companion diagnostics

Pharmacogenomics and Personalized Medicine

Volumn 8, Issue , 2015, Pages 99-110

  Agarwal, Amit ^a   Ressler, Dan ^b   Snyder, Glenn ^a  

^a Deloitte Touche Tohmatsu   (United States)

^b Deloitte Consulting LLP   (United States)

Author keywords

Companion diagnostics; Monitoring; Personalized medicine; Prognosis; Theranostics

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CLOPIDOGREL; DECITABINE; ERLOTINIB; EVEROLIMUS; IMATINIB; IRINOTECAN; IVACAFTOR; MARAVIROC; MENINGOCOCCUS VACCINE; MERCAPTOPURINE; MERICITABINE; ORTERONEL; RECOMBINANT SOMATOMEDIN C; REGORAFENIB; RETINOIC ACID; RITUXIMAB; TAMOXIFEN; TICAGRELOR; TRASTUZUMAB;

CLINICAL TRIAL (TOPIC); COMPANION DIAGNOSTICS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HUMAN; MEDICAL INFORMATION; MOLECULAR DIAGNOSIS; NOMENCLATURE; PERSONALIZED MEDICINE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROCESS DEVELOPMENT; PUBLIC-PRIVATE PARTNERSHIP; REIMBURSEMENT; REVIEW;

EID: 84936992040     PISSN: None     EISSN: 11787066     Source Type: Journal    
DOI: 10.2147/PGPM.S49493     Document Type: Review

References (28)

1. US Food and Drug Administration. Companion diagnostics [webpage on the Internet]. Available from: http://www. fda. gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm407297. htm. Accessed August 26, 2014.
2. Myriad Genetics [webpage on the Internet]. 2013 Annual Report. Available from: http://files. shareholder. com/downloads/MYGN/3422924703x0x699241/42B88246-0E90-4F5C-9697-3DF98027C46D/2013_Annual_Report. pdf. Accessed August 26, 2014.
3. Dutton G. Companion Dx and personalized medicine [webpage on the Internet]. Genetic Engineering and Biotechnology News. 2012; 32(19). Available from: http://www. genengnews. com/gen-articles/companion-dx-and-personalized-medicine/4577. Accessed August 26, 2014.
4. Hughes MD. Molecular Diagnostics Market Trends and Outlook [webpage on the Internet]. Enterprise Analysis Corporation; 2013. Available from: http://www. eacorp. com/images/PDFS/Molecular%20Diagnostics%20IVD%20Article%20v21%20MEK%20-%20Reprint%20FINAL. pdf. Accessed August 26, 2014.
5. Visiongain [webpage on the Internet]. Companion Diagnostics: World Market Outlook 2011-2021. Available from: https://www. visiongain. com/Report/675/Companion-Diagnostics-World-Market-Outlook-2011-2021. Accessed August 26, 2014.
6. Personalized Medicine Coalition. The Case for Personalized Medicine. Washington, DC: Personalized Medicine Coalition; 2006.
7. Analysis by authors utilizing FDA labels at Daily Med (http://dailymed. nlm. nih. gov). Accessed August 26, 2014.
8. Personalized Medicine Coalition. The Case for Personalized Medicine. Washington, DC: Personalized Medicine Coalition; 2011.
9. Singh V. Companion diagnostics poised for a breakout. The Burrill Report [webpage on the Internet]. 2012; 2(9). Available from: http://www. burrillreport. com/content/BR_0912%20final-v3. pdf. Accessed August 26, 2014.
10. Roche [webpage on the Internet]. Annual Reports Archive; 2012 [updated July 28, 2014]. Available from: http://www. roche. com/investors/annual_reports/annual_reports_archive. htm. Accessed August 26, 2014.
11. Novartis [webpage on the Internet]. Annual Report 2012; 2012. Available from: http://www. novartis. com/downloads/investors/reports/novartis-annual-report-2012-en. pdf. Accessed August 26, 2014.
12. Surveying Tomorrow's BioPharma Landscape [webpage on the Internet]. Evaluate Pharma; 2012. Available from: http://info. evaluatepharma. com/rs/evaluatepharmaltd/images/EvaluatePharma_NBI_Up_Close_2012. pdf. Accessed August 26, 2014.
13. Review of clinical trials listed at http://www. clinicaltrials. gov. Accessed on August 26, 2014.
14. Review of EMA drugs labels at http://www. ema. europa. eu/ema/index. jsp?curl=pages/regulation/document_listing/document_listing_000267. jsp. Accessed August 26, 2014.
15. Carver HC. Companion diagnostics: evolving FDA regulation and issues for resolution. In Danzis SD, Flannery EJ, editors. In Vitro Diagnostics: The Complete Regulatory Guide. Washington, DC: Food and Drug Law Institute; 2010: 149-184.
16. Titus K. Two for the road with companion diagnostics [webpage on the Internet]. CAP Today; 2012. Available from: http://www. cap. org/apps//cap. portal?_nfpb=true&cntvwrPtlt_actionOverride=%2Fportlets%2FcontentViewer%2Fshow&_windowLabel=cntvwrPtlt&cntvwrPtlt{actionForm. contentReference}=cap_today%2F0412%2F0412b_diagnostics. html&_state=maximized&_pageLabel=cntvwr. Accessed August 26, 2014.
17. Roche. Roche provides update on Phase III study of onartuzumab in people with specific type of lung cancer [press release]. March 3, 2014. Available from: http://www. roche. com/media/media_releases/med-cor-2014-03-03. htm. Accessed August 26, 2014.
18. The Academy of Medical Sciences. "Realising the Potential of Stratified Medicine" Case Studies; 2012. Available from: http://www. acmedsci. ac. uk/viewFile/51f28620d5ec6. pdf. Accessed August 26, 2014.
19. Smith B, Ransom J, Spinner D, Faulkner E. Future Best Practices in Oncology Development. Quintiles White Paper. Available from: http://www. quintiles. com/library/white-papers/future-best-practices-in-oncology-development-critical-aspects-of-codeveloping-and-launching-an. Accessed November 21, 2014.
20. Roche. 2013 Annual Report. Available from: http://www. roche. com/investors/annual_reports. htm. Accessed August 26, 2014.
21. Datamonitor PharmaVitae Database. https://service. datamonitorhealthcare. com/drug/drug-search/. Accessed March 20, 2014.
22. Wildwood Ventures Ltd. Current Agreements Database. Available from: http://www. currentagreements. com/. Accessed Nov 2013.
23. Garfield S. Advancing Access to Personalized Medicine: A Comparative Assessment of European Reimbursement Systems. Personalized Medicine Coalition. Bridgehead International; 2011; Available from: http://www. personalizedmedicinecoalition. org/Userfiles/PMC-Corporate/file/pmc_bridgehead_issue_brief_european_reimbursement. pdf. Accessed November 21, 2014.
24. Crook A. Better access to molecular tests: the INCa/Pfizer partnership. EuropaBio 2011: Workshop on Market Access to Personalized Medicine. Feb 9 Brussels, Belgium. Available from: http://www. europabio. org/sites/default/files/3_-_access_to_molecular_tests_europabio_pers_med_workshop_090211. pd. Accessed March 20, 2014.
25. Merrill J, Bonanos P, Lash A, LaMotta L, Haas J, Goodman M. Deals of the week wonders: will pharma ever pay more for companion diagnostics? The Pink Sheet, November 25, 2013. Available from: http://invivoblog. blogspot. com/2013/11/deals-of-week-wonders-will-pharma-ever. html. Accessed August 26, 2014.
26. Leamon CP, Sherman MA. The rise of companion diagnostics: a step towards truly personalized medicine. Oncology Business Review. May 2012. Available from: https://obroncology. com/obrgreen/article/The-Rise-of-Companion-Diagnostics-A%20Step-Towards-Truly-Personalized-Medicine. Accessed August 26, 2014.
27. Genomic Health. 2012 Genomic Health Annual Report. Available from: http://investor. genomichealth. com/annuals. cfm. Accessed August 26, 2014.
28. Informa Strategic Transactions Database for In Vitro Diagnostics and Research Tools. https://www. pharmamedtechbi. com/mkt/db/transactions/st-lp. Accessed March 20, 2014.